{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:28:35Z","timestamp":1787016515709,"version":"build-2736575974"},"reference-count":12,"publisher":"American Society for Microbiology","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/501100003605","name":"Korea International Cooperation Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1128\/aac.01984-17","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T08:05:54Z","timestamp":1513843554000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar"],"prefix":"10.1128","volume":"62","author":[{"given":"Wah Wah","family":"Aung","sequence":"first","affiliation":[{"name":"Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyu Win","family":"Ei","sequence":"additional","affiliation":[{"name":"Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wint Wint","family":"Nyunt","sequence":"additional","affiliation":[{"name":"National Tuberculosis Program, Department of Public Health, Naypyitaw, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Mi","family":"Htwe","sequence":"additional","affiliation":[{"name":"Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Mon","family":"Win","sequence":"additional","affiliation":[{"name":"Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay Thi","family":"Aye","sequence":"additional","affiliation":[{"name":"Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye Su","family":"Mon","sequence":"additional","affiliation":[{"name":"Advanced Molecular Research Centre, Department of Medical Research, Yangon, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Thu","family":"Aung","sequence":"additional","affiliation":[{"name":"National Tuberculosis Program, Department of Public Health, Naypyitaw, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chulhun L.","family":"Chang","sequence":"additional","affiliation":[{"name":"Pusan National University Yangsan Hospital, Yangsan, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[{"name":"International Tuberculosis Research Center, Changwon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","volume-title":"Global tuberculosis report 2016","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Global tuberculosis report 2016. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/tb\/publications\/global_report\/en\/."},{"key":"e_1_3_2_3_2","volume-title":"Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Guidelines for treatment of drug-susceptible tuberculosis and patient care, 2017 update. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/255052\/1\/9789241550000-eng.pdf."},{"key":"e_1_3_2_4_2","volume-title":"Treatment guidelines for drug resistant tuberculosis, 2016 update","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Treatment guidelines for drug resistant tuberculosis, 2016 update. World Health Organization, Geneva, Switzerland. http:\/\/apps.who.int\/iris\/bitstream\/10665\/250125\/1\/9789241549639-eng.pdf."},{"key":"e_1_3_2_5_2","volume-title":"The shorter MDR-TB regimen","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. The shorter MDR-TB regimen. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/tb\/Short_MDR_regimen_factsheet.pdf."},{"key":"e_1_3_2_6_2","first-page":"6","article-title":"The curious characteristics of pyrazinamide: a review","volume":"7","author":"Zhang Y","year":"2003","unstructured":"Zhang Y, Mitchison D. 2003. The curious characteristics of pyrazinamide: a review. Int J Tuberc Lung Dis 7:6\u201321.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00110-08"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.5.1670-1674.2002"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000002"},{"key":"e_1_3_2_10_2","volume-title":"The NCBI handbook","author":"Madden T","year":"2013","unstructured":"Madden T. 2013. The BLAST sequence analysis tool, 2013 March 15. In The NCBI handbook, 2nd ed. National Center for Biotechnology Information, Bethesda, MD. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK153387\/.","edition":"2"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.01819-14"},{"key":"e_1_3_2_12_2","first-page":"82","article-title":"Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing","volume":"6","author":"Shenai S","year":"2009","unstructured":"Shenai S, Rodrigues C, Sadnai M, Sukhadia N, Mehta A. 2009. Comparison of phenotypic and genotypic methods for pyrazinamide susceptibility testing. Indian J Tuberc 6:82\u201390.","journal-title":"Indian J Tuberc"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30190-6"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01984-17","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.01984-17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T16:08:10Z","timestamp":1645459690000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.01984-17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1128\/AAC.01984-17"],"URL":"https:\/\/doi.org\/10.1128\/aac.01984-17","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"2018-02-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01984-17"}}